{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T14:32:34Z","timestamp":1779114754939,"version":"3.51.4"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI170574"],"award-info":[{"award-number":["R01AI170574"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Microbiol"],"DOI":"10.1038\/s41564-025-01977-x","type":"journal-article","created":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T02:35:51Z","timestamp":1743215751000},"page":"1145-1155","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["ERK pathway reactivation prevents anthrax toxin lethality in mice"],"prefix":"10.1038","volume":"10","author":[{"given":"Jie","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zehua","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Ewing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6993-0789","authenticated-orcid":false,"given":"Qing","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6471-1993","authenticated-orcid":false,"given":"Liu","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0726-3546","authenticated-orcid":false,"given":"Toren","family":"Finkel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen H.","family":"Leppla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3444-1069","authenticated-orcid":false,"given":"Shihui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,28]]},"reference":[{"key":"1977_CR1","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.tim.2014.02.012","volume":"22","author":"S Liu","year":"2014","unstructured":"Liu, S., Moayeri, M. & Leppla, S. H. Anthrax lethal and edema toxins in anthrax pathogenesis. Trends Microbiol. 22, 317\u2013325 (2014).","journal-title":"Trends Microbiol."},{"key":"1977_CR2","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1146\/annurev-micro-091014-104523","volume":"69","author":"M Moayeri","year":"2015","unstructured":"Moayeri, M., Leppla, S. H., Vrentas, C., Pomerantsev, A. P. & Liu, S. Anthrax pathogenesis. Annu. Rev. Microbiol. 69, 185\u2013208 (2015).","journal-title":"Annu. Rev. Microbiol."},{"key":"1977_CR3","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.ijmm.2007.09.007","volume":"298","author":"MJ Hudson","year":"2008","unstructured":"Hudson, M. J. et al. Bacillus anthracis: balancing innocent research with dual-use potential. Int. J. Med. Microbiol. 298, 345\u2013364 (2008).","journal-title":"Int. J. Med. Microbiol."},{"key":"1977_CR4","first-page":"843","volume":"109","author":"R Grunow","year":"2012","unstructured":"Grunow, R. et al. Injection anthrax\u2014a new outbreak in heroin users. Dtsch. Arztebl. Int. 109, 843\u2013848 (2012).","journal-title":"Dtsch. Arztebl. Int."},{"key":"1977_CR5","doi-asserted-by":"crossref","first-page":"20204","DOI":"10.2807\/ese.17.26.20204-en","volume":"17","author":"T Holzmann","year":"2012","unstructured":"Holzmann, T. et al. Fatal anthrax infection in a heroin user from southern Germany, June 2012. Euro Surveill. 17, 20204 (2012).","journal-title":"Euro Surveill."},{"key":"1977_CR6","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1128\/CVI.00023-06","volume":"13","author":"R Mabry","year":"2006","unstructured":"Mabry, R. et al. Detection of anthrax toxin in the serum of animals infected with Bacillus anthracis by using engineered immunoassays. Clin. Vaccine Immunol. 13, 671\u2013677 (2006).","journal-title":"Clin. Vaccine Immunol."},{"key":"1977_CR7","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.toxicon.2008.08.011","volume":"52","author":"F Dal Molin","year":"2008","unstructured":"Dal Molin, F. et al. Ratio of lethal and edema factors in rabbit systemic anthrax. Toxicon 52, 824\u2013828 (2008).","journal-title":"Toxicon"},{"key":"1977_CR8","volume":"15","author":"J Liu","year":"2024","unstructured":"Liu, J. et al. Anthrax lethal toxin exerts potent metabolic inhibition of the cardiovascular system. mBio 15, e0216024 (2024).","journal-title":"mBio"},{"key":"1977_CR9","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1128\/iai.59.10.3472-3477.1991","volume":"59","author":"C Pezard","year":"1991","unstructured":"Pezard, C., Berche, P. & Mock, M. Contribution of individual toxin components to virulence of Bacillus anthracis. Infect. Immun. 59, 3472\u20133477 (1991).","journal-title":"Infect. Immun."},{"key":"1977_CR10","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1099\/00221287-139-10-2459","volume":"139","author":"C Pezard","year":"1993","unstructured":"Pezard, C., Duflot, E. & Mock, M. Construction of Bacillus anthracis mutant strains producing a single toxin component. J. Gen. Microbiol. 139, 2459\u20132463 (1993).","journal-title":"J. Gen. Microbiol."},{"key":"1977_CR11","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1093\/cid\/cis017","volume":"54","author":"AW Artenstein","year":"2012","unstructured":"Artenstein, A. W. & Opal, S. M. Novel approaches to the treatment of systemic anthrax. Clin. Infect. Dis. 54, 1148\u20131161 (2012).","journal-title":"Clin. Infect. Dis."},{"key":"1977_CR12","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1086\/512372","volume":"44","author":"JJ Walsh","year":"2007","unstructured":"Walsh, J. J. et al. A case of naturally acquired inhalation anthrax: clinical care and analyses of anti-protective antigen immunoglobulin G and lethal factor. Clin. Infect. Dis. 44, 968\u2013971 (2007).","journal-title":"Clin. Infect. Dis."},{"key":"1977_CR13","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1056\/NEJMoa0810603","volume":"361","author":"TS Migone","year":"2009","unstructured":"Migone, T. S. et al. Raxibacumab for the treatment of inhalational anthrax. N. Engl. J. Med. 361, 135\u2013144 (2009).","journal-title":"N. Engl. J. Med."},{"key":"1977_CR14","volume":"16","author":"BM Head","year":"2016","unstructured":"Head, B. M., Rubinstein, E. & Meyers, A. F. Alternative pre-approved and novel therapies for the treatment of anthrax. BMC Infect. Dis. 16, 621 (2016).","journal-title":"BMC Infect. Dis."},{"key":"1977_CR15","doi-asserted-by":"publisher","unstructured":"Tournier, J. N., Rougeaux, C., Biot, F. V. & Goossens, P. L. Questionable efficacy of therapeutic antibodies in the treatment of anthrax. mSphere https:\/\/doi.org\/10.1128\/mSphere.00282-19 (2019).","DOI":"10.1128\/mSphere.00282-19"},{"key":"1977_CR16","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.jmb.2009.07.037","volume":"392","author":"AF Kintzer","year":"2009","unstructured":"Kintzer, A. F. et al. The protective antigen component of anthrax toxin forms functional octameric complexes. J. Mol. Biol. 392, 614\u2013629 (2009).","journal-title":"J. Mol. Biol."},{"key":"1977_CR17","doi-asserted-by":"crossref","first-page":"9058","DOI":"10.1074\/jbc.M113.452110","volume":"288","author":"DD Phillips","year":"2013","unstructured":"Phillips, D. D. et al. Engineering anthrax toxin variants that exclusively form octamers and their application to targeting tumors. J. Biol. Chem. 288, 9058\u20139065 (2013).","journal-title":"J. Biol. Chem."},{"key":"1977_CR18","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1083\/jcb.200211018","volume":"160","author":"L Abrami","year":"2003","unstructured":"Abrami, L., Liu, S., Cosson, P., Leppla, S. H. & van der Goot, F. G. Anthrax toxin triggers endocytosis of its receptor via a lipid raft-mediated clathrin-dependent process. J. Cell Biol. 160, 321\u2013328 (2003).","journal-title":"J. Cell Biol."},{"key":"1977_CR19","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.mam.2009.06.003","volume":"30","author":"RJ Collier","year":"2009","unstructured":"Collier, R. J. Membrane translocation by anthrax toxin. Mol. Aspects Med. 30, 413\u2013422 (2009).","journal-title":"Mol. Aspects Med."},{"key":"1977_CR20","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1126\/science.280.5364.734","volume":"280","author":"NS Duesbery","year":"1998","unstructured":"Duesbery, N. S. et al. Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor. Science 280, 734\u2013737 (1998).","journal-title":"Science"},{"key":"1977_CR21","doi-asserted-by":"crossref","first-page":"e17165","DOI":"10.1371\/journal.pone.0017165","volume":"6","author":"CS Lee","year":"2011","unstructured":"Lee, C. S. et al. MEK2 is sufficient but not necessary for proliferation and anchorage-independent growth of SK-MEL-28 melanoma cells. PLoS ONE 6, e17165 (2011).","journal-title":"PLoS ONE"},{"key":"1977_CR22","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1006\/bbrc.1998.9040","volume":"248","author":"G Vitale","year":"1998","unstructured":"Vitale, G. et al. Anthrax lethal factor cleaves the N-terminus of MAPKKs and induces tyrosine\/threonine phosphorylation of MAPKs in cultured macrophages. Biochem. Biophys. Res. Commun. 248, 706\u2013711 (1998).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1977_CR23","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1042\/bj3520739","volume":"352","author":"G Vitale","year":"2000","unstructured":"Vitale, G., Bernardi, L., Napolitani, G., Mock, M. & Montecucco, C. Susceptibility of mitogen-activated protein kinase kinase family members to proteolysis by anthrax lethal factor. Biochem. J. 352, 739\u2013745 (2000).","journal-title":"Biochem. J."},{"key":"1977_CR24","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1038\/s41564-020-0782-1","volume":"5","author":"MA Mendenhall","year":"2020","unstructured":"Mendenhall, M. A. et al. Anthrax lethal factor cleaves regulatory subunits of phosphoinositide-3 kinase to contribute to toxin lethality. Nat. Microbiol. 5, 1464\u20131471 (2020).","journal-title":"Nat. Microbiol."},{"key":"1977_CR25","first-page":"E4079","volume":"113","author":"S Liu","year":"2016","unstructured":"Liu, S. et al. Solid tumor therapy by selectively targeting stromal endothelial cells. Proc. Natl Acad. Sci. USA 113, E4079\u2013E4087 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1977_CR26","doi-asserted-by":"crossref","first-page":"e20532","DOI":"10.1371\/journal.pone.0020532","volume":"6","author":"JM Schafer","year":"2011","unstructured":"Schafer, J. M. et al. Efficient targeting of head and neck squamous cell carcinoma by systemic administration of a dual uPA and MMP-activated engineered anthrax toxin. PLoS ONE 6, e20532 (2011).","journal-title":"PLoS ONE"},{"key":"1977_CR27","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1158\/1535-7163.MCT-09-0694","volume":"9","author":"RW Alfano","year":"2010","unstructured":"Alfano, R. W. et al. Inhibition of tumor angiogenesis by the matrix metalloproteinase-activated anthrax lethal toxin in an orthotopic model of anaplastic thyroid carcinoma. Mol. Cancer Ther. 9, 190\u2013201 (2010).","journal-title":"Mol. Cancer Ther."},{"key":"1977_CR28","volume":"1","author":"Z Zuo","year":"2022","unstructured":"Zuo, Z. et al. A potent tumor-selective ERK pathway inactivator with high therapeutic index. PNAS Nexus 1, pgac104 (2022).","journal-title":"PNAS Nexus"},{"key":"1977_CR29","volume":"120","author":"Z Zuo","year":"2023","unstructured":"Zuo, Z. et al. ERK and c-Myc signaling in host-derived tumor endothelial cells is essential for solid tumor growth. Proc. Natl Acad. Sci. USA 120, e2211927120 (2023).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1977_CR30","doi-asserted-by":"crossref","first-page":"17919","DOI":"10.1074\/jbc.M117.805648","volume":"292","author":"W Ouyang","year":"2017","unstructured":"Ouyang, W., Guo, P., Fang, H. & Frucht, D. M. Anthrax lethal toxin rapidly reduces c-Jun levels by inhibiting c-Jun gene transcription and promoting c-Jun protein degradation. J. Biol. Chem. 292, 17919\u201317927 (2017).","journal-title":"J. Biol. Chem."},{"key":"1977_CR31","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/nature12510","volume":"501","author":"S Liu","year":"2013","unstructured":"Liu, S. et al. Key tissue targets responsible for anthrax-toxin-induced lethality. Nature 501, 63\u201368 (2013).","journal-title":"Nature"},{"key":"1977_CR32","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1128\/IAI.01781-06","volume":"75","author":"AM Firoved","year":"2007","unstructured":"Firoved, A. M. et al. Anthrax edema toxin sensitizes DBA\/2J mice to lethal toxin. Infect. Immun. 75, 2120\u20132125 (2007).","journal-title":"Infect. Immun."},{"key":"1977_CR33","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1128\/IAI.74.1.682-693.2006","volume":"74","author":"AP Pomerantsev","year":"2006","unstructured":"Pomerantsev, A. P., Sitaraman, R., Galloway, C. R., Kivovich, V. & Leppla, S. H. Genome engineering in Bacillus anthracis using Cre recombinase. Infect. Immun. 74, 682\u2013693 (2006).","journal-title":"Infect. Immun."},{"key":"1977_CR34","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.chom.2010.10.004","volume":"8","author":"S Liu","year":"2010","unstructured":"Liu, S. et al. Anthrax toxin targeting of myeloid cells through the CMG2 receptor is essential for establishment of Bacillus anthracis infections in mice. Cell Host Microbe 8, 455\u2013462 (2010).","journal-title":"Cell Host Microbe"},{"key":"1977_CR35","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1042\/BJ20100323","volume":"429","author":"A Cuadrado","year":"2010","unstructured":"Cuadrado, A. & Nebreda, A. R. Mechanisms and functions of p38 MAPK signalling. Biochem. J. 429, 403\u2013417 (2010).","journal-title":"Biochem. J."},{"key":"1977_CR36","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ceb.2007.02.001","volume":"19","author":"CR Weston","year":"2007","unstructured":"Weston, C. R. & Davis, R. J. The JNK signal transduction pathway. Curr. Opin. Cell Biol. 19, 142\u2013149 (2007).","journal-title":"Curr. Opin. Cell Biol."},{"key":"1977_CR37","doi-asserted-by":"publisher","unstructured":"Hotamisligil, G. S. & Davis, R. J. Cell signaling and stress responses. Cold Spring Harb. Perspect. Biol. https:\/\/doi.org\/10.1101\/cshperspect.a006072 (2016).","DOI":"10.1101\/cshperspect.a006072"},{"key":"1977_CR38","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1074\/jbc.M116.761734","volume":"292","author":"AB Goldberg","year":"2017","unstructured":"Goldberg, A. B., Cho, E., Miller, C. J., Lou, H. J. & Turk, B. E. Identification of a substrate-selective exosite within the metalloproteinase anthrax lethal factor. J. Biol. Chem. 292, 814\u2013825 (2017).","journal-title":"J. Biol. Chem."},{"key":"1977_CR39","doi-asserted-by":"crossref","first-page":"5175","DOI":"10.1128\/IAI.00719-07","volume":"75","author":"M Moayeri","year":"2007","unstructured":"Moayeri, M., Wiggins, J. F. & Leppla, S. H. Anthrax protective antigen cleavage and clearance from the blood of mice and rats. Infect. Immun. 75, 5175\u20135184 (2007).","journal-title":"Infect. Immun."},{"key":"1977_CR40","doi-asserted-by":"crossref","first-page":"5897","DOI":"10.1007\/s11033-011-1401-2","volume":"39","author":"M Vuyisich","year":"2012","unstructured":"Vuyisich, M., Sanders, C. K. & Graves, S. W. Binding and cell intoxication studies of anthrax lethal toxin. Mol. Biol. Rep. 39, 5897\u20135903 (2012).","journal-title":"Mol. Biol. Rep."},{"key":"1977_CR41","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1038\/ncb3608","volume":"19","author":"Y Dondelinger","year":"2017","unstructured":"Dondelinger, Y. et al. MK2 phosphorylation of RIPK1 regulates TNF-mediated cell death. Nat. Cell Biol. 19, 1237\u20131247 (2017).","journal-title":"Nat. Cell Biol."},{"key":"1977_CR42","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.molcel.2017.05.003","volume":"66","author":"I Jaco","year":"2017","unstructured":"Jaco, I. et al. MK2 phosphorylates RIPK1 to prevent TNF-induced cell death. Mol. Cell 66, 698\u2013710.e5 (2017).","journal-title":"Mol. Cell"},{"key":"1977_CR43","doi-asserted-by":"crossref","unstructured":"Van Hauwermeiren, F. et al. Bacillus anthracis induces NLRP3 inflammasome activation and caspase-8-mediated apoptosis of macrophages to promote lethal anthrax. Proc. Natl Acad. Sci. USA 119, e2116415119 (2022).","DOI":"10.1073\/pnas.2116415119"},{"key":"1977_CR44","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1074\/jbc.M707419200","volume":"283","author":"S Liu","year":"2008","unstructured":"Liu, S. et al. Matrix metalloproteinase-activated anthrax lethal toxin demonstrates high potency in targeting tumor vasculature. J. Biol. Chem. 283, 529\u2013540 (2008).","journal-title":"J. Biol. Chem."},{"key":"1977_CR45","first-page":"2251","volume":"8","author":"I Lugowska","year":"2015","unstructured":"Lugowska, I., Kosela-Paterczyk, H., Kozak, K. & Rutkowski, P. Trametinib: a MEK inhibitor for management of metastatic melanoma. Onco Targets Ther. 8, 2251\u20132259 (2015).","journal-title":"Onco Targets Ther."},{"key":"1977_CR46","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s41586-020-2760-4","volume":"588","author":"ZM Khan","year":"2020","unstructured":"Khan, Z. M. et al. Structural basis for the action of the drug trametinib at KSR-bound MEK. Nature 588, 509\u2013514 (2020).","journal-title":"Nature"},{"key":"1977_CR47","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00418-018-1736-z","volume":"151","author":"M Nikaido","year":"2019","unstructured":"Nikaido, M. et al. Anisomycin, a JNK and p38 activator, suppresses cell\u2013cell junction formation in 2D cultures of K38 mouse keratinocyte cells and reduces claudin-7 expression, with an increase of paracellular permeability in 3D cultures. Histochem. Cell Biol. 151, 369\u2013384 (2019).","journal-title":"Histochem. Cell Biol."},{"key":"1977_CR48","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1111\/j.1440-1746.1994.tb01307.x","volume":"9","author":"M Itoh","year":"1994","unstructured":"Itoh, M. & Matsuo, Y. Gastric ulcer treatment with intravenous human epidermal growth factor: a double-blind controlled clinical study. J. Gastroenterol. Hepatol. 9, S78\u2013S83 (1994).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"1977_CR49","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.jpedsurg.2006.10.039","volume":"42","author":"PB Sullivan","year":"2007","unstructured":"Sullivan, P. B. et al. Intestinal mucosa remodeling by recombinant human epidermal growth factor1-48 in neonates with severe necrotizing enterocolitis. J. Pediatr. Surg. 42, 462\u2013469 (2007).","journal-title":"J. Pediatr. Surg."},{"key":"1977_CR50","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1742-481X.2009.00622.x","volume":"6","author":"J Berlanga-Acosta","year":"2009","unstructured":"Berlanga-Acosta, J. et al. Epidermal growth factor in clinical practice - a review of its biological actions, clinical indications and safety implications. Int. Wound. J. 6, 331\u2013346 (2009).","journal-title":"Int. Wound. J."},{"key":"1977_CR51","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1126\/science.1198701","volume":"332","author":"MC Good","year":"2011","unstructured":"Good, M. C., Zalatan, J. G. & Lim, W. A. Scaffold proteins: hubs for controlling the flow of cellular information. Science 332, 680\u2013686 (2011).","journal-title":"Science"},{"key":"1977_CR52","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/nature09860","volume":"472","author":"DF Brennan","year":"2011","unstructured":"Brennan, D. F. et al. A Raf-induced allosteric transition of KSR stimulates phosphorylation of MEK. Nature 472, 366\u2013369 (2011).","journal-title":"Nature"},{"key":"1977_CR53","doi-asserted-by":"crossref","first-page":"10374","DOI":"10.1074\/jbc.M010271200","volume":"276","author":"AJ Bardwell","year":"2001","unstructured":"Bardwell, A. J., Flatauer, L. J., Matsukuma, K., Thorner, J. & Bardwell, L. A conserved docking site in MEKs mediates high-affinity binding to MAP kinases and cooperates with a scaffold protein to enhance signal transmission. J. Biol. Chem. 276, 10374\u201310386 (2001).","journal-title":"J. Biol. Chem."},{"key":"1977_CR54","doi-asserted-by":"crossref","unstructured":"Romero-Becerra, R. et al. MKK6 deficiency promotes cardiac dysfunction through MKK3-p38\u03b3\/\u03b4-mTOR hyperactivation. eLife 11, e75250 (2022).","DOI":"10.7554\/eLife.75250"},{"key":"1977_CR55","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.pep.2011.05.016","volume":"80","author":"AP Pomerantsev","year":"2011","unstructured":"Pomerantsev, A. P. et al. A Bacillus anthracis strain deleted for six proteases serves as an effective host for production of recombinant proteins. Protein Expr. Purif. 80, 80\u201390 (2011).","journal-title":"Protein Expr. Purif."},{"key":"1977_CR56","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/j.1462-5822.2006.00845.x","volume":"9","author":"S Liu","year":"2007","unstructured":"Liu, S., Leung, H. J. & Leppla, S. H. Characterization of the interaction between anthrax toxin and its cellular receptors. Cell. Microbiol. 9, 977\u2013987 (2007).","journal-title":"Cell. Microbiol."},{"key":"1977_CR57","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/labinvest.2010.5","volume":"90","author":"BE Hall","year":"2010","unstructured":"Hall, B. E. et al. Conditional overexpression of TGF-\u03b21 disrupts mouse salivary gland development and function. Lab. Invest. 90, 543\u2013555 (2010).","journal-title":"Lab. Invest."},{"key":"1977_CR58","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/hmg\/ddm076","volume":"16","author":"SV Bradley","year":"2007","unstructured":"Bradley, S. V. et al. Degenerative phenotypes caused by the combined deficiency of murine HIP1 and HIP1r are rescued by human HIP1. Hum. Mol. Genet. 16, 1279\u20131292 (2007).","journal-title":"Hum. Mol. Genet."},{"key":"1977_CR59","doi-asserted-by":"crossref","first-page":"e1000906","DOI":"10.1371\/journal.ppat.1000906","volume":"6","author":"ZL Newman","year":"2010","unstructured":"Newman, Z. L. et al. Susceptibility to anthrax lethal toxin-induced rat death is controlled by a single chromosome 10 locus that includes rNlrp1. PLoS Pathog. 6, e1000906 (2010).","journal-title":"PLoS Pathog."},{"key":"1977_CR60","first-page":"503","volume":"120","author":"LE Reynolds","year":"2006","unstructured":"Reynolds, L. E. & Hodivala-Dilke, K. M. Primary mouse endothelial cell culture for assays of angiogenesis. Methods Mol. Med. 120, 503\u2013509 (2006).","journal-title":"Methods Mol. Med."},{"key":"1977_CR61","doi-asserted-by":"crossref","first-page":"5227","DOI":"10.1074\/jbc.M210321200","volume":"278","author":"S Liu","year":"2003","unstructured":"Liu, S. & Leppla, S. H. Cell surface tumor endothelium marker 8 cytoplasmic tail-independent anthrax toxin binding, proteolytic processing, oligomer formation, and internalization. J. Biol. Chem. 278, 5227\u20135234 (2003).","journal-title":"J. Biol. Chem."},{"key":"1977_CR62","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nmeth.3047","volume":"11","author":"NE Sanjana","year":"2014","unstructured":"Sanjana, N. E., Shalem, O. & Zhang, F. Improved vectors and genome-wide libraries for CRISPR screening. Nat. Methods 11, 783\u2013784 (2014).","journal-title":"Nat. Methods"},{"key":"1977_CR63","doi-asserted-by":"crossref","first-page":"12424","DOI":"10.1073\/pnas.0905409106","volume":"106","author":"S Liu","year":"2009","unstructured":"Liu, S. et al. Capillary morphogenesis protein-2 is the major receptor mediating lethality of anthrax toxin in vivo. Proc. Natl Acad. Sci. USA 106, 12424\u201312429 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"}],"container-title":["Nature Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41564-025-01977-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41564-025-01977-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41564-025-01977-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T14:49:29Z","timestamp":1746542969000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41564-025-01977-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,28]]},"references-count":63,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["1977"],"URL":"https:\/\/doi.org\/10.1038\/s41564-025-01977-x","relation":{},"ISSN":["2058-5276"],"issn-type":[{"value":"2058-5276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,28]]},"assertion":[{"value":"19 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}